Tirzepatide vs Semaglutide

Tirzepatide Vs Semaglutide
Synedica Health | UK Education

Tirzepatide vs Semaglutide: 7 Key Differences Explained

Compare mechanisms, weight-loss research, side effects and UK prescribing considerations in this evidence-based guide.

View Comparison →
Research Comparison

Tirzepatide vs Semaglutide: Which Is Different and Why?

Tirzepatide vs semaglutide is one of the most important comparisons in modern incretin-based weight-management research.

Both compounds influence metabolic pathways involved in appetite, blood glucose regulation and body weight. However, they differ in receptor activity, clinical trial findings, licensed product formulations and individual prescribing considerations.

Tirzepatide is the active ingredient in Mounjaro, while semaglutide is the active ingredient in medicines including Wegovy and Ozempic. Their approved indications are not identical across every brand and formulation.

Tirzepatide vs Semaglutide Comparison Table

The following table compares the two active ingredients and representative licensed UK products.

FeatureTirzepatideSemaglutide
Receptor activityGIP and GLP-1GLP-1
UK brand examplesMounjaroWegovy, Ozempic
Medicine classDual incretin receptor agonistGLP-1 receptor agonist
Weight-management useLicensed for eligible patientsWegovy licensed for eligible patients
Weekly injection optionsYesYes
Oral formulationsNo licensed oral tirzepatide product identified hereLicensed oral semaglutide formulations exist
Prescription requiredYesYes
Common side effectsNausea, diarrhoea, vomiting, constipationNausea, diarrhoea, vomiting, constipation

Note: Product indications and formulations can change. Always consult the specific licensed product information.

Mechanism of Action

How Do Tirzepatide and Semaglutide Work?

Tirzepatide activates both GIP and GLP-1 receptors. These signalling pathways affect insulin secretion, appetite and metabolic regulation.

Semaglutide acts on the GLP-1 receptor. It influences glucose regulation, appetite and gastric emptying.

The difference in receptor activity helps explain why the two medicines can produce different average results in clinical trials.

Explore tirzepatide effects →
Tirzepatide vs semaglutide GLP-1 comparison illustration
Clinical Research

Tirzepatide vs Semaglutide Weight-Loss Results

The SURMOUNT-5 trial directly compared tirzepatide with semaglutide in adults with obesity but without type 2 diabetes. It included 751 randomised participants.

20.2% Mean weight reduction with tirzepatide at 72 weeks
13.7% Mean weight reduction with semaglutide at 72 weeks
Trial outcomeTirzepatideSemaglutide
Average weight change at week 72-20.2%-13.7%
Average waist circumference change-18.4 cm-13.0 cm
Treatment period72 weeks72 weeks
Study population Adults with obesity but without type 2 diabetes

In this particular study, tirzepatide produced a greater average reduction in body weight and waist circumference. Individual responses vary, and this result does not establish that one treatment is suitable for every patient.

Read the original SURMOUNT-5 study in The New England Journal of Medicine →

7 Key Differences Between Tirzepatide and Semaglutide

01

Receptor Targets

Tirzepatide acts on GIP and GLP-1 receptors. Semaglutide targets GLP-1 receptors.

02

Average Trial Outcomes

Tirzepatide produced greater mean weight reduction in the specific SURMOUNT-5 comparison.

03

Brand Names

Tirzepatide is marketed as Mounjaro. Semaglutide is used in products including Wegovy and Ozempic.

04

Available Formulations

Both have injectable options. Semaglutide also has licensed oral formulations.

05

Side-Effect Profiles

Both commonly cause gastrointestinal symptoms. The frequency and severity vary by treatment, dose and individual.

06

Licensed Indications

Indications depend on the specific medicine and formulation. Not every semaglutide product has the same approved uses.

07

Individual Suitability

Clinical history, contraindications, other medicines and treatment goals influence prescribing decisions.

Tirzepatide vs semaglutide weight management research image
Safety Considerations

Side Effects and Important Safety Differences

Both medicines can cause nausea, vomiting, diarrhoea, constipation and abdominal discomfort.

More serious adverse reactions are possible. Prescribers consider medical history, other treatments, relevant contraindications and monitoring requirements.

Neither medicine should be selected solely on the basis of a comparison chart or average trial outcome.

Medical and research-use notice: Licensed medicines require appropriate prescribing and dispensing. Research-labelled peptides are not interchangeable with authorised medicines and must not be used for human self-administration.

Tirzepatide vs Semaglutide in the UK

UK readers commonly encounter tirzepatide under the Mounjaro brand and semaglutide under brands such as Wegovy and Ozempic. Both are prescription-only medicines.

Approved uses, clinical eligibility, available formulations and prescribing conditions must be checked against the relevant product documentation.

For additional educational reading, explore our Tirzepatide UK guide and tirzepatide effects article .

Tirzepatide vs Semaglutide FAQs

Is tirzepatide more effective than semaglutide for weight loss?

In SURMOUNT-5, tirzepatide produced greater average weight loss than semaglutide over 72 weeks. This finding applies to the trial population and treatment regimens studied; individual results vary.

What is the main difference between tirzepatide and semaglutide?

Tirzepatide activates both GIP and GLP-1 receptors, whereas semaglutide acts on GLP-1 receptors.

Is Mounjaro tirzepatide or semaglutide?

Mounjaro contains tirzepatide. Wegovy and Ozempic contain semaglutide.

Do tirzepatide and semaglutide have similar side effects?

Both commonly cause gastrointestinal adverse effects, including nausea, diarrhoea and vomiting. Their complete safety information should be reviewed separately.

Are both medicines available in the UK?

Licensed tirzepatide and semaglutide medicines are available in the UK for specified indications, subject to prescribing requirements and availability.

Can tirzepatide and semaglutide be used together?

They should not be combined on personal initiative. Any change between therapies requires assessment by a qualified prescriber.

Does the SURMOUNT-5 trial prove tirzepatide is best for everyone?

No. It demonstrated greater mean weight reduction in a defined study population. Treatment suitability depends on many clinical factors.

Continue Exploring GLP-1 Research

Discover further educational articles about tirzepatide, receptor mechanisms, clinical studies and UK medicine information.

Explore Tirzepatide UK →

One thought on “Tirzepatide vs Semaglutide”

  1. Pingback: Can Tirzepatide UK Be Trusted | Millions Of Testimonies

Leave a Reply

Your email address will not be published. Required fields are marked *